Orticumab
Orticumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Orticumab is under investigation in clinical trial NCT04776629 (A Proof-of-activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors).
| Trade Name | Orticumab |
| Generic | Orticumab |
| Orticumab Other Names | Orticumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Orticumab
